Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.95ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.95ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.95NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.36.26ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.36.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.26NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.531ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.531ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.531ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.531NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17890.7US
B.1.1.45ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.45ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.45ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.45NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.200ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.200ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.200ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.200NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.299ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.299ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.299ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.299NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.55ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.55ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.55ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.55NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.149ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.149ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.149ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.149NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.300ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.300ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.300ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.300NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.179ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.179ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.179ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.179NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.25ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.25ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.25NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.125ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.125ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.125ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used